BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11285852)

  • 1. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
    Zhou J; Jin H; Li Y; Jiang T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new extracorporeal reactor-dialyzer for enzyme therapy using immobilized L-asparaginase.
    Jackson JA; Halvorson HR; Furlong JW; Lucast KD; Shore JD
    J Pharmacol Exp Ther; 1979 May; 209(2):271-4. PubMed ID: 439002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in researches on L-asparaginase targeted to childhood leukemia].
    Cui YQ; Chen FX; Wu ZL
    Zhonghua Er Ke Za Zhi; 2004 Mar; 42(3):227-30. PubMed ID: 15144726
    [No Abstract]   [Full Text] [Related]  

  • 4. Monolith and coating enzymatic microreactors of L-asparaginase: kinetics study by MCE-LIF for potential application in acute lymphoblastic leukemia (ALL) treatment.
    Qiao J; Qi L; Mu X; Chen Y
    Analyst; 2011 May; 136(10):2077-83. PubMed ID: 21461410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor enzyme: polyethylene glycol-modified asparaginase.
    Wada H; Imamura I; Sako M; Katagiri S; Tarui S; Nishimura H; Inada Y
    Ann N Y Acad Sci; 1990; 613():95-108. PubMed ID: 2076022
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
    Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
    Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of acute leukemias with L-asparaginase].
    Senn HJ
    Praxis; 1969 May; 58(21):669-70. PubMed ID: 5819625
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
    Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
    Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of leukemia with L-asparaginase].
    Libánský J; Lukásová M
    Vnitr Lek; 1972 Feb; 18(2):138-49. PubMed ID: 5011126
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complete remission of lymphosarcoma cell leukemia with BACOP and L-asparaginase therapy--report of a case (author's transl)].
    Tachibana A; Kimoto M; Yamaguchi H; Asai I; Tsukada T
    Rinsho Ketsueki; 1977 Oct; 18(10):1260-5. PubMed ID: 592502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent advances in L-asparaginase studies].
    Taguchi T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1815-25. PubMed ID: 3285797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of L-asparaginase in the chemotherapy of tumors].
    Cardinali G
    Policlinico Prat; 1969 Mar; 76(9):276-80. PubMed ID: 4887557
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme therapy of cancer, future studies.
    Holcenberg JS
    Cancer Treat Rep; 1981; 65 Suppl 4():61-5. PubMed ID: 7346158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the treatment of acute leukemias].
    Popescu ER; Butoianu E; Nicoară ST
    Med Interna (Bucur); 1969 Sep; 21(9):1037-49. PubMed ID: 5378236
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
    Nervi C; Casale C; Cortese M
    Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of antineoplastic activity of extracellular asparaginase produced by isolated Bacillus circulans.
    Prakasham RS; Hymavathi M; Subba Rao Ch; Arepalli SK; Venkateswara Rao J; Kennady PK; Nasaruddin K; Vijayakumar JB; Sarma PN
    Appl Biochem Biotechnol; 2010 Jan; 160(1):72-80. PubMed ID: 19543838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion trials with a collagen-immobilized enzyme in an extracorporeal reactor: activity, stability, and biocompatibility.
    Olanoff LS; Venkatasubramanian K; Bernath FR; Joyeuse R
    J Biomed Mater Res; 1977 Jan; 11(1):125-36. PubMed ID: 845182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-asparaginase in the treatment of leukemia].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtini E; Bruschelli M; Astaldi A
    Przegl Lek; 1971; 27(3):286-9. PubMed ID: 5280473
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-asparaginase, a new drug of antileukemic action].
    Hernádi F
    Orv Hetil; 1969 Jan; 110(4):187-9. PubMed ID: 5779083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.